Petlife Pharmaceuticals, Inc. announced that effective May 30, 2018, Laura De Leon Castro resigned as Chief Executive Office, President, Secretary, Treasurer, Chief Financial Officer, and a Director of the company. Concurrently, Sebastian Serrell-Watts was appointed Chief Executive Officer, President, Secretary, Treasurer, Chief Financial Officer, and Chairman of the Board of Directors of the company. Sebastian Serrell-Watts, 53, has more than 20 years of business experience spanning manufacturing, pharmaceuticals, financial services, and entertainment, with expertise in capital raising, finance structure, sales, marketing, IPO execution, M&A. From June 2009 through December 2012, Mr. Serrell-Watts was a financial advisor with Kovack Securities.

Beginning in January 2012 served as Executive Vice President and a Board member of Medolife Corp. until November 2015. He served in the same capacities at Medolife's spin-off entity, publicly-traded PetLife Pharmaceuticals, Inc., through November 2015.

From November 2015 to present, Mr. Serrell-Watts has served as Chief Operating Officer and a Board member of Eclectic Pictures. From May 2016 to present he has service as a Consultant to DIVA Pharmaceuticals, Inc. He has also served as Consultant to Calmare Therapeutics, Inc. from December 2017 to present.